Delphine Sculier
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial
Courlet P, Decosterd L, Alves Saldanha S, Guidi M, Limacher A, Schmid P, Günthard H, Smit M, Marinosci A, Cavassini M, Vernazza P, Braun D, Bernasconi E, Stoeckle M, Wandeler G, Sculier D, Barbieux C, Calmy A. Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial. Br J Clin Pharmacol 2021
25.03.2021Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial
25.03.2021Br J Clin Pharmacol 2021
Courlet Perrine, Decosterd Laurent Arthur, Alves Saldanha Susana, Guidi Monia, Limacher Andreas, Schmid Patrick, Günthard Huldrych F, Smit Mikaela, Marinosci Annalisa, Cavassini Matthias, Vernazza Pietro, Braun Dominique, Bernasconi Enos, Stoeckle Marcel, Wandeler Gilles, Sculier Delphine, Barbieux Charlotte, Calmy Alexandra
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial
Sculier D, Calmy A, Egger M, Limacher A, Schmid P, Günthard H, Decosterd L, Metzner K, Buzzi M, Cavassini M, Veraguth K, Braun D, Bernasconi E, Stoeckle M, Marinosci A, Yerly S, Wandeler G, and the Swiss HIV Cohort Study (SHCS). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial. PLoS Med 2020; 17:e1003421.
10.11.2020Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial
10.11.2020PLoS Med 2020; 17:e1003421
Sculier Delphine, Calmy Alexandra, Egger Matthias, Limacher Andreas, Schmid Patrick, Günthard Huldrych F, Decosterd Laurent A, Metzner Karin J, Buzzi Marta, Cavassini Matthias, Veraguth Katja, Braun Dominique L, Bernasconi Enos, Stoeckle Marcel, Marinosci Annalisa, Yerly Sabine, Wandeler Gilles, and the Swiss HIV Cohort Study (SHCS)
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
Sculier D, Calmy A, Bernasconi E, Schmid P, Hirzel C, Fehr J, Cavassini M, Battegay M, Gayet-Ageron A, Swiss HIV Cohort Study. Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. BMC Infect Dis 2017; 17:476.
06.07.2017Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
06.07.2017BMC Infect Dis 2017; 17:476
Sculier Delphine, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Hirzel Cédric, Fehr Jan, Cavassini Matthias, Battegay Manuel, Gayet-Ageron Angèle, Swiss HIV Cohort Study